1012.56.01029 Boehringer Ingelheim Investigational Site

Los Angeles, California

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) — Completed